Clinical Trials Browser

OTHER × Lymphoma, Follicular × atezolizumab × Clear all

NCT04962126 2025-03-21

FLUORO

Phase 2 Active not recruiting

Lymphoma, Follicular

NCT03276468 2023-01-10

Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas

Phase 2 Completed

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone